MENU
+Compare
MGX
Stock ticker: NASDAQ
AS OF
Dec 26 closing price
Price
$1.70
Change
-$0.04 (-2.30%)
Capitalization
63.83M

MGX Metagenomi Forecast, Technical & Fundamental Analysis

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox... Show more

MGX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MGX with price predictions
Dec 26, 2025

MGX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for MGX turned positive on November 28, 2025. Looking at past instances where MGX's MACD turned positive, the stock continued to rise in of 13 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MGX's RSI Oscillator exited the oversold zone, of 12 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 16 cases where MGX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MGX advanced for three days, in of 81 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 40 cases where MGX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MGX as a result. In of 27 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.358) is normal, around the industry mean (26.614). P/E Ratio (0.000) is within average values for comparable stocks, (51.532). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (2.046) is also within normal values, averaging (310.546).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MGX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MGX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MGX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
5959 Horton Street
Phone
+1 510 871-4880
Employees
236
Web
https://www.metagenomi.co
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXGCF1.480.20
+15.53%
Nexgold Mining Corp
GTHP0.360.03
+8.27%
Guided Therapeutics, Inc.
BDOUY23.190.53
+2.34%
BDO Unibank Inc.
NGCRF0.60N/A
N/A
Nagacorp Ltd.
SLMNP850.00-20.00
-2.30%
LYONDELLBASELL ADVANCED POLYMERS INC.

MGX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with BEAM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
+1.16%
BEAM - MGX
53%
Loosely correlated
+1.33%
CRSP - MGX
52%
Loosely correlated
+0.44%
FATE - MGX
46%
Loosely correlated
+3.40%
CRBU - MGX
46%
Loosely correlated
+3.61%
CADL - MGX
45%
Loosely correlated
+3.58%
More